Skip to main content

Osteoarticular Regeneration

Advanced stem cell therapy for natural joint and cartilage regeneration.

Experiencing Joint pain or Cartilage wear? There are alternatives to surgery.

Our treatment offers a non-invasive, science-backed solution that uses your own Stem Cells to naturally repair joints and cartilage—no prosthetics, no surgery, just real regeneration..

This is more than restoring movement… It’s about reclaiming your life

Imagine running with your kids, hiking without pain, or simply enjoying everyday moments again. With your own Stem Cells, we help your body heal itself—naturally, safely, and powerfully.

Experiencing Joint Pain or Cartilage Wear caused by conditions such as:

CARTILAGE LESIONS

Cartilage lesions, often an early sign of osteoarthritis, are a common target of our treatment, which helps relieve chronic joint pain and stiffness.

TENDON AND MUSCLE INJURIES

Tendon and muscle injuries often affect active individuals, especially in high-impact sports. They can also be linked to muscle imbalances or endocrine issues like thyroid disorders.

ARTHROSIS

Arthrosis is a degenerative disease that wears down joint cartilage—and sometimes bone—causing painful friction and limited mobility.

Degenerative conditions affecting bones, cartilage, and tendons typically result in pain, swelling, and stiffness, which can restrict range of motion and limit movement.

These degenerative processes can only be effectively treated through Regenerative Medicine, as other therapies merely alleviate the symptoms without addressing the underlying cause.

Why Mesenchymal Stem Cell (MSC)?

Regenerative treatments like Mesenchymal Stem Cell Therapy, work at the root cause—not just on the surface – because it addresses the causes of hair loss, not just the symptoms.
MSC- based treatments aim to reverse or slow the aging process at the cellular level by stimulating tissue repair and regeneration.
Our treatment offers a non-invasive, science-backed solution that uses Mesenchymal Stem Cells to naturally repair joints and cartilage — no drug, no prosthetics, no surgery, just tissue regeneration – because MSCs can differentiate into specific cells of joint tissues, such as:

  • Chondrocytes (cartilage cells)
  • Osteoblasts (bone cells)
  • Tenocytes (tendon cells)

This enables the structural regeneration of damaged tissues, such as cartilage, subchondral bone, or tendons. MSCs replace damaged cells and create a microenvironment that promotes regeneration and reduces inflammation, making them particularly effective in treating joint disorders such as osteoarthritis, cartilage injuries, bone necrosis, and tendinopathies.

A cutting-edge Mesenchymal Stem Cell Therapy for:

The procedure is specifically targeted at orthopedic problems ailing the shoulder, hip, knee, ankle, and other joints in the body:

  • Osteoarthritis
  • Conditions associated with inflammation and tissue damage
  • Cartilage degeneration
  • Bone fractures or non-unions
  • Tendon or ligament injuries
  • Avascular necrosis
  • Avascular necrosis
  • Cartilage injuries

Conventional Treatments offer temporary, symptom-focused relief only. Here’s why:

This enables the structural regeneration of damaged tissues, such as cartilage, subchondral bone, or tendons. MSCs replace damaged cells and create a microenvironment that promotes regeneration and reduces inflammation, making them particularly effective in treating joint disorders such as osteoarthritis, cartilage injuries, bone necrosis, and tendinopathies.

STROMAL VASCULAR FRACTION (SVF)

Regardless of the method used for its extraction, SVF offers no therapeutic benefit and often worsens inflammation, especially in joints, due to the high content of macrophages that trigger inflammatory responses. Moreover, the number of stem cells present in SVF is inadequate—only a few thousand cells—while effective treatment requires tens of millions. Expanded MSCs, cultured and tested under controlled conditions, provide a significantly higher therapeutic cell dose, with a superior safety profile and lower risk of adverse reactions compared to heterogeneous, unquantified products like SVF.

PLATELET-RICH PLASMA (PRP)

Though often marketed as a regenerative medicine product, PRP has no true regenerative function. It contains growth factors that temporarily stimulate the injected area but do not regenerate damaged tissues. Expanded MSCs have a significantly greater capacity to regenerate cartilage than PRP or SVF, due to their ability to differentiate into chondrocytes that can repair and renew damaged tissue.

HYALURONIC ACID

While it improves joint lubrication and provides short-term relief, it does not halt the degenerative process. As a result, patients are often subjected to an ongoing cycle of palliative treatments. While hyaluronic acid provides temporary (and progressively diminishing) relief by improving joint lubrication, MSCs offer long-term benefits by altering the course of the disease through their regenerative action.

DRUGS

Pharmaceutical treatments target only symptoms—such as pain—without addressing the root causes. Moreover, they often come with serious medium- and long-term side effects (e.g., corticosteroids), which can accelerate joint degeneration and ultimately lead to surgical interventions such as joint replacement.

How do Mesenchymal Stem Cells work?

Mesenchymal stem cells replace damaged/old musculoskeletal cells: Chondrocytes (cartilage cells), Osteoblasts (bone cells) and Tenocytes (tendon cells).

  • Tissue Regeneration
    The new and youthful, Chondrocytes, Osteoblasts and Tenocytes, produce the new cartilage, bone and tendon needed to avoid the degenerative processes.
  • Inflammation Modulation
    Mesenchymal Stem Cells have a powerful immunomodulatory effect that reduces pain and inflammation within the joint, providing symptomatic relief and improving mobility
  • Secretion of Trophic Factors
    Mesenchymal Stem Cells promote healing and tissue regeneration through the secretion of growth factors and cytokines that stimulate the repair and regeneration of surrounding tissues.
  • Prevention of further Degeneration
    Mesenchymal Stem Cells slow down or sometimes prevent the progression of degenerative diseases through their ability to remodel and strengthen connective tissue.

LONG-TERM BENEFITS AND REDUCED TREATMENT FREQUENCY

Thanks to their ability to induce meaningful and lasting biological changes, expanded MSC (Mesenchymal Stem Cell) injections require fewer sessions than conventional treatments like hyaluronic acid or SVF. Their regenerative capacity and standardization make them a more reliable and scientifically sound approach for treating degenerative conditions.

Mesenchymal stem cells are the only treatment capable of achieving this result by addressing the root causes and not just its symptoms.
The second mechanism of action is to secrete exosomes that modulate the behavior of resident musculoskeletal cells boosting self-renewal and regeneration.

Let’s clarify with accurate information:

Stem Cells obtained from a fat sample require at least two weeks of processing before they can be used; otherwise, the treatment is ineffective and potentially harmful:

  • Fat that is harvested and manipulated for use in the same session is both useless and harmful.
  • There are no Stem Cells in the blood, so treatments claiming to use stem cells extracted from blood are not scientifically valid. The Stem Cells used to treat hematological diseases are found in the bone marrow, not in the blood.
  • The hematopoietic stem cells found in umbilical cord blood are useful for treating blood disorders, but not for counteracting the aging processes of the human body

Expected Timeline

  • Week 1–2: Initial Phase
    Mild soreness or swelling at the injection site. No immediate improvement in joint symptoms.
  • Week 3–6: Onset of Improvement
    Gradual reduction in pain and stiffness. Improved range of motion. Early signs of reduced inflammation in RA patients.
  • Month 2–4: Peak of Symptomatic Relief
    Significant pain relief for many patients. Improved joint function. Enhanced daily activity capacity.
  • Month 5–12: Stabilization / Maintenance
    Sustained improvement in most responders. A possible booster injection may be considered in some protocols.

Why choose Bioscience Treatment for Osteoarticular Regeneration

Discover all the advantages of the regenerative power of stem cells to naturally heal joint pain and cartilage wear

Why Orthopedic Physicians choose MSC Therapy first?

Addressing Degenerative Joint and Bone Conditions at the Root Orthopedic medicine is rapidly evolving—from symptom management to true regeneration.
Today, Mesenchymal Stem Cells (MSCs) represent the most scientifically advanced and ethically responsible treatment for cartilage and bone degeneration.

Biocompatible, Non-Toxic, and Genotoxicity-Free

MSC treatments—especially when autologous—carry minimal risk of immune reaction or side effects. Unlike corticosteroids or NSAIDs, they do not harm the body over time.Choosing the safest therapeutic option is both a clinical and ethical imperative.

Medical Responsibility Means Preserving Native Tissue

In orthopedics, delaying or avoiding joint replacement is always preferable—especially in younger patients. MSCs help preserve native cartilage, improve joint function, and reduce reliance on invasive procedures. From a professional standpoint, conserving tissue and preventing disability is a higher standard of care.

Long-Term Relief, Not Repeated Injections

Painkillers and steroids may offer fast relief but require frequent repetition, with cumulative toxicity and long-term joint damage. MSC therapy, by contrast, often requires fewer sessions and provides sustained benefits. Repeated symptomatic treatments without addressing the biological damage may be convenient—but not ethical.

Regenerative Medicine Respects the Cause, Not Just the Consequences

Conventional treatments such as corticosteroids, hyaluronic acid, painkillers, or even early surgical procedures only suppress symptoms like inflammation or pain—while the underlying degeneration silently progresses. MSC therapy works differently: it promotes true repair by stimulating cartilage regeneration, reducing inflammation, and slowing structural deterioration. A physician’s ethical duty is to treat the cause, not just cover it up.

Leading the Shift Toward Regenerative Orthopedics

MSC therapy is not an experimental approach—it is supported by robust clinical evidence and is already transforming how orthopedic degeneration is treated. Ethical leadership means guiding patients toward innovative, evidence-based care—not waiting for outdated standards to change. An orthopedic specialist committed to professional excellence and patient well-being cannot ignore the clinical superiority and biological intelligence of stem cell–based therapies. Choosing MSCs first is not only scientifically justified—it is ethically necessary.

Your Skin’s Journey to Renewal - Real Results, Step by Step

MSC therapy is a promising regenerative and anti-inflammatory approach. It can improve quality of life, reduce symptoms, and slow progression, but the outcomes depend on patient selection and disease stage. For this reason, a CONSULTATION WITH AN ORTHOPEDIC SPECIALIST IS ESSENTIAL.

Reduce joint pain and inflammation

lorem ipsum lorem ipsum lorem ipsum

Greater mobility and less stiffness

lorem ipsum lorem ipsum lorem ipsum

Stimulate some degree of cartilage repair

lorem ipsum lorem ipsum lorem ipsum

Why MSC Treatments save you money compared to conventional ones?

Mesenchymal stem cell (MSC) therapy for osteoarticular regeneration may seem more expensive at first — but it actually helps you save money over time by targeting the root causes of joint degeneration and reducing the need for continuous symptom-based treatments.
Instead of managing pain temporarily, it promotes true tissue repair and long-term functional recovery, minimizing the cumulative cost of repeated therapies.

  • Regenerative, Not Temporary
    Unlike traditional treatments such as corticosteroid injections, hyaluronic acid, or physical therapy — which only offer short-term symptom relief — MSC therapy supports the biological regeneration of cartilage, tendons, and joint tissues. It promotes natural healing, improves mobility, and helps restore joint structure and function.
  • Fewer sessions, longer-lasting results – Reduced Need for Repetitive Treatments
    Conventional approaches often require frequent sessions every few months to maintain relief. MSC therapy, on the other hand, offers sustained improvements for 6–12 months or longer, especially when combined with a personalized rehabilitation plan.
  • You spend less over time – One Treatment = Multiple Benefits
    A single MSC treatment can simultaneously help:• Reduce inflammation and pain
    • Improve joint mobility and flexibility
    • Stimulate cartilage repair
    • Slow down degenerative progression
    • Delay or even prevent surgical interventionThis means you avoid combining multiple temporary treatments to achieve similar outcomes.
  • Slows Down Degeneration Progression
    By addressing the biological mechanisms behind osteoarticular degeneration, MSC therapy delays or eliminates the need for more invasive procedures such as prosthetic surgery or repeated infiltrations. It’s a smarter, long-term investment in your mobility, comfort, and joint health.

In-depth Information

Would you like to explore further or learn more? Access comprehensive explanations by expanding the sections below.

Differences between Adipose-Derived and Umbilical Cord-Derived Stem Cells

Mesenchymal stem cells are the same regardless of whether they are derived from Adipose Tissue or Umbilical Cord Tissue. The only difference lies in their biological age, which reflects the age of the tissue of origin.

Adipose Tissue Derived Stem Cells
The treatment requires a fat collection, stem cell extraction, and expansion. The entire process takes approximately 2–3 weeks. Therefore, from the moment of fat harvesting, a waiting period of 2–3 weeks is necessary before the treatment can be performed.

Umbilical Cord Tissue derived Stem Cells
The treatment does not require fat harvesting and can be performed within 2–3 days of the request.

Stromal Vascular Fraction (SVF) VS Mesenchymal Stem Cells (MSC)

In the regenerative medicine landscape, many providers offer therapies labeled as “Stem Cell treatments” that utilize Stromal Vascular Fraction (SVF)—a heterogeneous mix of cells extracted from adipose tissue. While SVF contains some Stem Cells, it also includes various other cell types, leading to variability in treatment outcomes.
At our Clinic, we prioritize precision and efficacy by exclusively using Mesenchymal Stem Cells (MSCs). These are meticulously isolated and expanded in controlled laboratory settings, ensuring a pure, potent, and standardized cell population. This approach enhances the therapeutic potential and consistency of our treatments.

×

Information Request








    Privacy Policy (*)